McMaster University

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

224

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

10 drugs in development

Approved1

Phase 32

Phase 22

Phase 14

Preclinical5

By Therapeutic Area

top 6

Infectious Disease

319%

Psychiatry

213%

Metabolic & Endocrine

16%

Cardiovascular

16%

Nephrology

16%

Oncology

16%

R&D Momentum

84/100

Pipeline Velocity

61/100

Trial Completion Rate

73/100

Pipeline Concentration

14/100

Pipeline Freshness

66/100

Strategic Signals

↗Active in Metabolic & Endocrine but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Nov 4, 2026

Recruiting

Investigation of Sex-differences the BDNF Response to Exercise

Oct 30, 2026

Recruiting

Evaluating a Virtual Peer-support Exercise Intervention for Older Adults With Cancer in Canada: The Partner4Exercise Randomized Controlled Trial

Oct 29, 2026

Recruiting

Mechanisms of Weight Loss Due to Dual GIP GLP-1 Receptor Agonism With Tirzepatide Compared to Semaglutide: A Randomized Controlled Trial

Oct 27, 2026

Recruiting

Exploring the Effect of Hormonal Contraceptives on Postprandial Glucose Handling in Young Healthy Females

Oct 23, 2026

Completed

The Effect of Cannabinoids vs. Placebo on Persistent Post-surgical Pain Following Total Knee Arthroplasty: A Multicenter, Randomized Pilot Trial

Oct 23, 2026

Recruiting

Ketamine Sedation in the Intensive Care Unit: a Pilot Randomized Controlled Trial

Earlier

Oct 21, 2026TrialMean Visual Acuity Changes Following Five Injections of Aflibercept and the Relationship Between Ocular and Serum Cytokine Levels and Mean Visual Acuity Gains in DME Patients

Oct 20, 2026TrialA 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough (FORTITUDE)

3 more events

Oct 17, 2026TrialImplementing Physical Activity for Individuals With Cancer During Treatment: The IMPACT Implementation-Effectiveness Trial

Oct 16, 2026TrialBridging Gaps, Enhancing Wellbeing: Examining the Effectiveness of the Technology-Enabled Collaborative Care for Diabetes and Mental Health (TECC-DM) Model

Oct 15, 2026TrialCompassionate Communities Neighbourhood Program: Cluster Randomized Trial

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Therapeutic Area

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Cardiovascular(1 drug)

—

Cardiovascular(1 drug)

Gastroenterology(1 drug)

—

Gastroenterology(1 drug)

Infectious Disease(3 drugs)

—

Infectious Disease(3 drugs)

Metabolic & Endocrine(1 drug)

—

Metabolic & Endocrine(1 drug)

Nephrology(1 drug)

—

Nephrology(1 drug)

Neurology(1 drug)

—

Neurology(1 drug)

Oncology(1 drug)

—

Oncology(1 drug)

Ophthalmology(1 drug)

—

Ophthalmology(1 drug)

Psychiatry(2 drugs)

—

Psychiatry(2 drugs)

Unknown / Other(4 drugs)

—

Unknown / Other(4 drugs)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)